Switch to:

Intra-Cellular Therapies Debt-to-Asset

: 0.06 As of Jun. 2020
View and export this data going back to 2013. Start your Free Trial

Intra-Cellular Therapies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $3.97 Mil. Intra-Cellular Therapies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $21.16 Mil. Intra-Cellular Therapies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2020 was $440.93 Mil. Intra-Cellular Therapies's debt to asset for the quarter that ended in Jun. 2020 was 0.06.


Intra-Cellular Therapies Debt-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Intra-Cellular Therapies Annual Data
Dec12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.09

Intra-Cellular Therapies Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.09 0.05 0.06

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Intra-Cellular Therapies Debt-to-Asset Distribution

* The bar in red indicates where Intra-Cellular Therapies's Debt-to-Asset falls into.



Intra-Cellular Therapies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Intra-Cellular Therapies's Debt-to-Asset for the fiscal year that ended in Dec. 2019 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.187 + 19.955) / 251.186
=0.09

Intra-Cellular Therapies's Debt-to-Asset for the quarter that ended in Jun. 2020 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.974 + 21.158) / 440.931
=0.06

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies  (NAS:ITCI) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Intra-Cellular Therapies Debt-to-Asset Related Terms


Intra-Cellular Therapies Debt-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)